Nick Pizzie, the Chief Financial Officer of $AXSM, sold 12,000 shares of the company on 01-22-2026 for an estimated $2,255,040. We received data on the trade from a recent SEC filing. This was a sale of approximately 22.0% of their shares of this class of stock. Following this trade, they now own 42,588 shares of this class of $AXSM stock.
$AXSM Insider Trading Activity
$AXSM insiders have traded $AXSM stock on the open market 32 times in the past 6 months. Of those trades, 3 have been purchases and 29 have been sales.
Here’s a breakdown of recent trading of $AXSM stock by insiders over the last 6 months:
- HERRIOT TABUTEAU (Chief Executive Officer) has made 0 purchases and 15 sales selling 491,590 shares for an estimated $70,125,820.
- ROGER JEFFS has made 0 purchases and 6 sales selling 110,158 shares for an estimated $13,373,843.
- MARK E SAAD has made 0 purchases and 3 sales selling 46,704 shares for an estimated $7,348,482.
- MARK L. JACOBSON (Chief Operating Officer) has made 0 purchases and 3 sales selling 55,783 shares for an estimated $6,400,726.
- NICK PIZZIE (Chief Financial Officer) sold 12,000 shares for an estimated $2,255,040
- ARI MAIZEL (Chief Commercial Officer) sold 7,500 shares for an estimated $1,383,300
- MARK COLEMAN has made 3 purchases buying 1,575 shares for an estimated $200,466 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AXSM Hedge Fund Activity
We have seen 197 institutional investors add shares of $AXSM stock to their portfolio, and 139 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BVF INC/IL removed 1,203,464 shares (-71.2%) from their portfolio in Q3 2025, for an estimated $146,160,702
- WELLINGTON MANAGEMENT GROUP LLP added 609,516 shares (+84.1%) to their portfolio in Q3 2025, for an estimated $74,025,718
- PRICE T ROWE ASSOCIATES INC /MD/ added 424,705 shares (+69.3%) to their portfolio in Q3 2025, for an estimated $51,580,422
- INVESCO LTD. added 419,008 shares (+73.3%) to their portfolio in Q3 2025, for an estimated $50,888,521
- BANK OF AMERICA CORP /DE/ removed 392,168 shares (-52.1%) from their portfolio in Q3 2025, for an estimated $47,628,803
- UBS GROUP AG removed 383,004 shares (-64.3%) from their portfolio in Q3 2025, for an estimated $46,515,835
- POINT72 ASSET MANAGEMENT, L.P. removed 332,259 shares (-94.7%) from their portfolio in Q3 2025, for an estimated $40,352,855
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$AXSM Analyst Ratings
Wall Street analysts have issued reports on $AXSM in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 01/20/2026
- UBS issued a "Buy" rating on 01/06/2026
- Needham issued a "Buy" rating on 12/31/2025
- Mizuho issued a "Outperform" rating on 11/06/2025
- RBC Capital issued a "Outperform" rating on 11/04/2025
- Morgan Stanley issued a "Overweight" rating on 11/04/2025
- B. Riley Securities issued a "Buy" rating on 10/01/2025
To track analyst ratings and price targets for $AXSM, check out Quiver Quantitative's $AXSM forecast page.
$AXSM Price Targets
Multiple analysts have issued price targets for $AXSM recently. We have seen 11 analysts offer price targets for $AXSM in the last 6 months, with a median target of $204.0.
Here are some recent targets:
- Leonid Timashev from RBC Capital set a target price of $219.0 on 01/21/2026
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $260.0 on 01/20/2026
- David Amsellem from Piper Sandler set a target price of $223.0 on 01/16/2026
- Benjamin Burnett from Wells Fargo set a target price of $193.0 on 01/13/2026
- Sean Laaman from Morgan Stanley set a target price of $204.0 on 01/08/2026
- Ashwani Verma from UBS set a target price of $248.0 on 01/06/2026
- Ami Fadia from Needham set a target price of $169.0 on 12/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.